Role of bile acids in inflammatory liver diseases
Open accessThe DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Abstract
Bile acids and their signaling pathways are increasingly recognized as potential therapeutic targets for cholestatic and metabolic liver diseases. This review summarizes new insights in bile acid physiology, focusing on regulatory roles of bile acids in the control of immune regulation and on effects of pharmacological modulators of bile acid signaling pathways in human liver disease. Recent mouse studies have highlighted the importance of the interactions between bile acids and gut microbiome. Interfering with microbiome composition may be beneficial for cholestatic and metabolic liver diseases by modulating formation of secondary bile acids, as different bile acid species have different signaling functions. Bile acid receptors such as FXR, VDR, and TGR5 are expressed in a variety of cells involved in innate as well as adaptive immunity, and specific microbial bile acid metabolites positively modulate immune responses of the host. Identification of Cyp2c70 as the enzyme responsible for the generation of hydrophilic mouse/rat-specific muricholic acids has allowed the generation of murine models with a human-like bile acid composition. These novel mouse models will aid to accelerate translational research on the (patho)physiological roles of bile acids in human liver diseases .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Their enterohepatic circulation allows them to act as hormones by stimulating nuclear receptors such as FXR in the gut and liver,40”
From An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH (2023) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease
Eslam, M., Sanyal, A. J., George, J., Sanyal, A., Neuschwander-Tetri, B., Tiribelli, C., Kleiner, D. E., Brunt, E., Bugianesi, E., Yki-Järvinen, H., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.312 · Cited by 3,286
Özcan, U., Yilmaz, E., Özcan, L., Furuhashi, M., Vaillancourt, E., Smith, R. O., Görgün, C. Z., & Hotamisligil, G. S. (2006) · Science · doi:10.1126/science.1128294 · Cited by 2,413
Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., Chalasani, N., Dasarathy, S., Diehl, A. M., Hameed, B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61933-4 · Cited by 2,237
Human Fatty Liver Disease: Old Questions and New Insights
Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2011) · Science · doi:10.1126/science.1204265 · Cited by 2,089
The Enzymes, Regulation, and Genetics of Bile Acid Synthesis
Russell, D. W. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161712 · Cited by 2,069
Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
Lefebvre, P., Cariou, B., Lien, F., Kuipers, F., & Staels, B. (2009) · Physiological Reviews · doi:10.1152/physrev.00010.2008 · Cited by 1,678
Self-citationLoomba, R., & Sanyal, A. J. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.171 · Cited by 1,641
A G Protein-coupled Receptor Responsive to Bile Acids
Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628
Bile acids: regulation of synthesis
Chiang, J. Y. L. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900010-jlr200 · Cited by 1,515
Cited by
An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH
Tacke, F., Puengel, T., Loomba, R., & Friedman, S. L. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.038 · Cited by 321
TNF in the liver: targeting a central player in inflammation
Tiegs, G., & Horst, A. K. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00910-2 · Cited by 224
Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics
Ma, X., Huang, T., Chen, X., Li, Q., Liao, M., Fu, L., Huang, J., Yuan, K., Wang, Z., & Zeng, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02104-8 · Cited by 133
Bile acid and receptors: biology and drug discovery for nonalcoholic fatty liver disease
Jiao, T., Ma, Y., Guo, X., Ye, Y., & Xie, C. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00880-z · Cited by 136
Mechanism of action of the bile acid receptor TGR5 in obesity
Lun, W., Yan, Q., Guo, X., Zhou, M., Bai, Y., He, J., Cao, H., Che, Q., Guo, J., & Su, Z. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.11.011 · Cited by 132
The Role of CYP3A in Health and Disease
Klyushova, L. S., Perepechaeva, M. L., & Grishanova, A. Y. (2022) · Biomedicines · doi:10.3390/biomedicines10112686 · Cited by 120
Cheong, K., Yu, B., Chen, J., & Zhong, S. (2022) · Foods · doi:10.3390/foods11223550 · Cited by 99
Unlocking gut-liver-brain axis communication metabolites: energy metabolism, immunity and barriers
Sun, X., Shukla, M., Wang, W., & Li, S. (2024) · npj Biofilms and Microbiomes · doi:10.1038/s41522-024-00610-9 · Cited by 118
Holtmann, T. M., Inzaugarat, M. E., Knorr, J., Geisler, L. J., Schulz, M., Bieghs, V., Frissen, M., Feldstein, A. E., Tacke, F., Trautwein, C., et al. (2021) · Cells · doi:10.3390/cells10102618 · Cited by 62
The gut microbiota-bile acid axis: a crucial regulator of immune function and metabolic health
Tyagi, A., & Kumar, V. (2025) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-025-04395-7 · Cited by 74
The Role of Bile Acids in the Human Body and in the Development of Diseases
Shulpekova, Y. O., Жаркова, М. С., Tkachenko, P. E., Тихонов, И. Н., Stepanov, A. A., Sinitsyna, A. A., Izotov, A., Butkova, T. V., Shulpekova, N. V., Лапина, Н. В., et al. (2022) · Molecules · doi:10.3390/molecules27113401 · Cited by 50
Bile Acids in Intrahepatic Cholestasis of Pregnancy
Majsterek, M., Wierzchowska-Opoka, M., Makosz, I., Kreczyńska, L. M., Kimber-Trojnar, Ż., & Leszczyńska‐Gorzelak, B. (2022) · Diagnostics · doi:10.3390/diagnostics12112746 · Cited by 46
Kaufmann, B. K., Seyfried, N., Hartmann, D., & Hartmann, P. (2023) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00017.2023 · Cited by 44
Alharthi, J., Pan, Z., Gloss, B., McLeod, D. J., Weltman, M., George, J., & Eslam, M. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155583 · Cited by 41
Non-SCFA microbial metabolites associated with fiber fermentation and host health
Grant, E. T., Franco, H. D., & Desai, M. S. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.06.009 · Cited by 45
Islam, M. S., Sharif, A., Kwan, N., & Tam, K. C. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00007 · Cited by 43
Wahlstrom, A. M., Aydin, Ö., Olsson, L. M., Sjöland, W., Henricsson, M., Lundqvist, A., Marschall, H., Franken, R. J., van de Laar, A. W. J. M., Gerdes, V. E. A., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105265 · Cited by 39
Xu, W., Zou, K., Zhan, Y., Cai, Y., Zhang, Z., Tao, X., Qiu, L., & Wei, H. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1020734 · Cited by 36
Yu, C., Xu, Y., Wei, Y., Guo, Y., Wang, Y., Song, P., & Yu, J. H. (2023) · Environmental Science and Pollution Research · doi:10.1007/s11356-023-31564-8 · Cited by 42
Chen, P., Wu, Z., Cui, Z., Liu, C., Lei, K., Tian, S., Mai, K., & Zhang, W. (2023) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2023.109114 · Cited by 31
Louca, P., Meijnikman, A. S., Nogal, A., Asnicar, F., Attaye, I., Vijay, A., Kouraki, A., Visconti, A., Wong, K. E., Berry, S. E., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.100993 · Cited by 29
Yang, C., Yang, L., Yang, Y., Wan, M., Xu, D., Pan, D., & Sun, G. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114864 · Cited by 31
Collaborative Metabolism: Gut Microbes Play a Key Role in Canine and Feline Bile Acid Metabolism
Rowe, J. C., & Winston, J. A. (2024) · Veterinary Sciences · doi:10.3390/vetsci11020094 · Cited by 31
Evangelakos, I., Schwinge, D., Worthmann, A., John, C., Roeder, N., Pertzborn, P., Behrens, J., Schramm, C., Scheja, L., & Heeren, J. (2021) · Cells · doi:10.3390/cells10102656 · Cited by 25
Self-citationDarmanto, A. G., Yen, T., Jan, J., Linh, T. T. D., Taliyan, R., Yang, C. H., & Sheu, J. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107564 · Cited by 25
Gut-liver axis in diabetes: Mechanisms and therapeutic opportunities
Abdalla, M. M. I. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i29.109090 · Cited by 30
Kang, M. H., Elnar, A. G., & Kim, G.-B. (2025) · Food Science of Animal Resources · doi:10.5851/kosfa.2025.e1 · Cited by 21
“Several study reports revealed that high blood cholesterol levels (LDL-C>190 mg/dL; Bittencourt et al., 2020), accompanied by a sedentary lifestyle, are increasingly prevalent across generations (Evangelakos et al., 2021; Perez and Briz, 2009; Sun et al., 2023).”
Lockhart, S. M., Mušo, M., Zvetkova, I., Lam, B., Ferrari, A., Schoenmakers, E., Duckett, K., Leslie, J., Collins, A., Romartínez-Alonso, B., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01126-4 · Cited by 24
Yan, S., Liu, S., Qu, J., Li, X., Hu, J., Zhang, L., Liu, X., Li, X., Wang, X., Wen, L., et al. (2022) · Nutrients · doi:10.3390/nu14030560 · Cited by 21
Zhao, J., Yang, Q., Liu, Z., Xu, P., Tian, L., Yan, J., Li, K., Lin, B., Bian, L., Xi, Z., et al. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.114573 · Cited by 21
The Mechanism of Antimicrobial Activity of Conjugated Bile Acids against Lactic Acid Bacilli
Chai, L., Wu, H. J., Wang, X., He, L., & Guo, C. (2023) · Microorganisms · doi:10.3390/microorganisms11071823 · Cited by 19
Galley, J. D., Rajasekera, T. A., Bennouna, D., Batabyal, A., Verosky, B. G., Woodke, S. T., Stokes, J., Brown, A. K., Murthy, S., Kopec, R. E., et al. (2024) · Beneficial Microbes · doi:10.1163/18762891-bja00047 · Cited by 18
Zhou, C., Zhang, W., Lin, H., Zhang, L., Wu, F., Wang, Y., Yu, S., Peng, X., Cheng, W., Li, M., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.925264 · Cited by 25
Li, X., Hu, L., Chu, H., Chen, L., Yan, J., Wang, W., Yang, X., Zhu, Q., Du, F., Song, Y., et al. (2022) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2021.00398 · Cited by 22
Yan, L.-S., Kang, J.-Y., Gu, C.-Y., Qiu, X., Li, J., Cheng, B. C., Wang, Y., Luo, G., & Zhang, Y. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119801 · Cited by 16
Zhang, B., Li, J., Zong, X., Wang, J., Xin, L., Song, H., Zhang, W., Koda, S., Hua, H. M., Zhang, B., et al. (2022) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0010651 · Cited by 25
Zhou, T., Ismail, A., & Francis, H. (2023) · Cells · doi:10.3390/cells12232725 · Cited by 14
Increased concentrations of conjugated bile acids are associated with osteoporosis in PSC patients
Stürznickel, J., Behler-Janbeck, F., Baranowsky, A., Schmidt, T., Schwinge, D., John, C., Lohse, A. W., Schramm, C., Heeren, J., Schinke, T., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-20351-z · Cited by 15
Self-citationKhocht, A., Paster, B. J., Lenoir, L., Irani, C., & Fraser, G. E. (2023) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13860 · Cited by 14
Wang, C., Fu, R., Xu, D., Zuo, Q., Liu, J.-P., & Tang, Y. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117369 · Cited by 14
Quantifying Forms and Functions of Enterohepatic Bile Acid Pools in Mice
Sudo, K., Eliason, A. D., Soucy, S. M., Barrack, K. E., Liu, J., Balasubramanian, A., Shu, C. J., James, M. J., Hegner, C. L., Dionne, H. D., et al. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.101392 · Cited by 14
Zhu, X., Xia, E.-Q., Liu, Y., Wei-Qiao, L. I., Yan, X. I. N., Lin, X., Marozik, P. M., & Guo, H. (2022) · Chinese Journal of Analytical Chemistry · doi:10.1016/j.cjac.2022.100175 · Cited by 12
Tang, X., Zhou, Y., Xia, L., Lin, X., Zhu, Y., Chen, M., Wang, J., & Li, Y. (2025) · Molecules · doi:10.3390/molecules30153066 · Cited by 13
Microbiome-derived bile acids as endogenous regenerative mediators in liver repair
Pandey, S. N., Goyal, K., Rana, M., Menon, S. V., Ray, S., Ali, H., Kumbhar, P., Disouza, J., Singh, S. K., Gupta, G., et al. (2025) · Regenerative Therapy · doi:10.1016/j.reth.2025.08.011 · Cited by 12
Altered hepatic metabolism in Down syndrome
Dunn, L. N., Niemeyer, B. F., Eduthan, N. P., Schade, K. A., Waugh, K. A., Brown, C., Rachubinski, A. L., Timkovich, A. E., Orlicky, D. J., Galbraith, M. D., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2025.116835 · Cited by 13
The contributions of bacteria metabolites to the development of hepatic encephalopathy
Gilbert, M. C., Setayesh, T., & Wan, Y. Y. (2022) · Liver Research · doi:10.1016/j.livres.2022.11.005 · Cited by 11
Chen, L., Wang, Y., Zheng, W., Zhang, H., Sun, Y., Chen, Y., & Liu, Q. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1097641 · Cited by 13
Wang, W., Lian, H., Liang, Y., Ye, Y., Tam, P. K. H., & Chen, Y. (2024) · Cells · doi:10.3390/cells13231997 · Cited by 13
Profiling of bile acids and activated receptor S1PR2 in gingival tissues of periodontitis patients
Yang, R., Yu, W., Lin, L., Jin, M., Hu, S., Jiang, B., Mao, C., Li, G., Tang, J., Gu, Y., et al. (2022) · Journal of Periodontology · doi:10.1002/jper.22-0398 · Cited by 30
Intestinal microbiota promoted NiONPs-induced liver fibrosis via effecting serum metabolism
Tang, J., Zhao, H., Li, K., Zhou, H., Chen, Q., Wang, H., Li, S., Xu, J., Sun, Y., & Chang, X. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.115943 · Cited by 11
PSC and colitis: A complex relationship
Horst, L. J., Kempski, J., Walmsley, M., Huber, S., & Schramm, C. (2025) · Hepatology · doi:10.1097/hep.0000000000001236 · Cited by 12
Dicks, L., Schuh, K., Prehn, C. P., Sadri, H., Muráni, E., Ghaffari, M. H., & Häussler, S. (2024) · Journal of Dairy Science · doi:10.3168/jds.2024-24346 · Cited by 14
Synthesis of 12β-methyl-18- nor -avicholic acid analogues as potential TGR5 agonists
Ure, E. M., Harris, L. D., Cameron, S. A., Weymouth‐Wilson, A., Furneaux, R. H., Pitman, J. L., Hinkley, S. F. R., & Luxenburger, A. (2022) · Organic & Biomolecular Chemistry · doi:10.1039/d1ob02401a · Cited by 9
Therapeutic Potential of Microbial Metabolites: New Insights and Perspectives
Hashmi, M. A. T. S., Khawar, M. B., Naseem, R., Afzal, A., Shahid, N., Abbasi, M. H., Sheikh, N., Afzal, N., Mukhtar, M., Shahzaman, S., et al. (2023) · Biomedical Research and Therapy · doi:10.15419/bmrat.v10i4.805 · Cited by 10
Bile Acid-conjugate as a Promising Anticancer Agent: Recent Progress
Rathod, N. V., & Mishra, S. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673274040231121113410 · Cited by 9
Emerging Therapeutic Strategies in the Fight Against Primary Biliary Cholangitis
Medford, A., Childs, J. R., Little, A., Chakraborty, S., Baiocchi, L., Alpini, G. D., & Glaser, S. S. (2023) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00398 · Cited by 11
NLRP3 and Gut–Liver Axis: New Possibility for the Treatment of Alcohol‐Associated Liver Disease
Dong, L., Zhang, H., Kang, Y., Wang, F., Bai, T., & Yang, Y. (2025) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16935 · Cited by 7
Exploring serum bile acids as potential noninvasive biomarkers for nonalcoholic fatty liver disease
Basuni, A. A., Sweed, D., Elgazzar, M. F., & Khalil, A. A. (2024) · Egyptian Liver Journal · doi:10.1186/s43066-024-00378-9 · Cited by 10
Lin, S., Huang, L., Wu, Y., Huang, L., Wu, P., Huang, T., Li, Z., & Hu, Y. (2023) · Journal of Chromatography B · doi:10.1016/j.jchromb.2023.123626 · Cited by 6
Deng, M., Tong, M., Fu, F., & Wei, D. (2023) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2023.105155 · Cited by 7
Indolfo, N. D. C., Ganzerla, M. D., Doratioto, T. R., Avelino, T. M., Tofani, L. B., Peroni, L. A., Rabelo, R. S., Arroteia, K. F., & Figueira, A. C. M. (2023) · Lab on a Chip · doi:10.1039/d3lc00546a · Cited by 9
Antony, F., Brough, Z., Orangi, M., Al‐Seragi, M., Aoki, H., Babu, M., & Duong, F. (2024) · PROTEOMICS · doi:10.1002/pmic.202300599 · Cited by 10
Goel, N., Choudhary, P., Pattanaik, L., Padhi, S. K., & Chaudhary, P. (2024) · Springer eBooks · doi:10.1007/978-981-97-1912-9_22 · Cited by 7
Eryptosis in Liver Diseases: Contribution to Anemia and Hypercoagulation
Kurmangaliyeva, S. S., Baktikulova, K., Tkachenko, A. S., Seitkhanova, B., Tryfonyuk, L., Rakhimzhanova, F. S., Yussupov, R., & Kurmangaliyev, K. B. (2025) · Medical Sciences · doi:10.3390/medsci13030125 · Cited by 12
Acierno, C., Caturano, A., Barletta, F., Rinaldi, L., Sasso, F. C., Adinolfi, L. E., & Nevola, R. (2026) · Nutrients · doi:10.3390/nu18111765 · Cited by 4
Chan, C. C. C., Lemos, M. L. P., Finnegan, P., Gagnon, W., Dean, R., Yazdanafar, M., Zepeda, J., Vohl, M., Trauner, M., Korzenik, J. R., et al. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101188 · Cited by 11
Tian, Y., Zhao, R., Xiao, S., Chen, L., Cheng, Y., Wei, M., Tang, Z., Cai, Y., Xiao, Z., Yi, A., et al. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1524987 · Cited by 4
Yu, Y., Yao, Q., Chen, D., Zhang, Z., Pan, Q., Yu, J., Cao, H., Li, L., & Li, J. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03967-y · Cited by 5
Mediators of liver inflammation and carcinogenesis
Herkel, J., & Schmidt‐Arras, D. (2021) · Seminars in Immunopathology · doi:10.1007/s00281-021-00880-x · Cited by 5
Nitsche, K. S., Sakolish, C., Carmichael, P. L., Hewitt, P. G., Bajaj, P., Ferguson, S., Lloyd, S. M., Wilson, S. S., Bouwmeester, H., & Rusyn, I. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04263-1 · Cited by 6
Jaiswar, D., Jeeyar, V., Choudhury, S., & Dixit, M. (2026) · Cancer Control · doi:10.1177/10732748261433619 · Cited by 4
Zhang, Z., Yang, X., Fu, Y., Wei, H., Chen, Y., Dai, A., Zhou, X., Wan, J., & Chen, W. (2025) · Fitoterapia · doi:10.1016/j.fitote.2025.106938 · Cited by 3
Bile Acids: A Bridge Linking Gut Microbiota and NAFLD
Zhang, J., Wang, C., Ji, X., Wu, F., Lin, Z., Zhou, Y., Xu, C., & Wang, F. (2022) · Advanced Gut & Microbiome Research · doi:10.1155/2022/4752148 · Cited by 3
Current trends and future perspectives in the treatment of PBC and PSC: A review
Das, D. D., Sharma, N., & Chawla, P. A. (2022) · Health Sciences Review · doi:10.1016/j.hsr.2022.100065 · Cited by 7
Mullapudi, T. R., Ravi, P. R., & Thipparapu, G. (2021) · Xenobiotica · doi:10.1080/00498254.2021.1998732 · Cited by 3
Rebuttal to: the benevolent bile: bile acids as stimulants of liver regeneration
Zhou, W., & Anakk, S. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.02.002 · Cited by 2
“late immune responses in the liver and contribute to the pathogenesis of inflammatory diseases.(6) BAs also activate cell death and survival pathways, and the balance between these signals determines the beneficial or toxic effects of specific BAs in the liver.”
BackgroundFan, Q., Guo, G., Hu, Y., Lu, Y., Su, R., Yang, J., Xia, E., Ma, S., Zhang, M., Wang, J., et al. (2025) · iScience · doi:10.1016/j.isci.2025.111804 · Cited by 3
Tan, P. Y., Loganathan, R., Lee, S. C., Johari, S. N. M., Teng, K., Selvaduray, K. R., & Lim, Y. A. L. (2025) · Nature Communications · doi:10.1038/s41467-025-64395-x · Cited by 3
Liu, C., Zhu, Z., Lin, H., Bush, W. S., Jenq, R. R., Cominelli, F., Pillai, J. A., Haines, J. L., Zhu, X., Xu, R., et al. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2026.1735332 · Cited by 2
Yang, Y., Ren, L., Zhang, Y., Wang, X., Shang, J., & Zhang, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1884030 · Cited by 2
Kuznetsov, Y. E., Lunegov, A. M., Ponamarev, V. S., & Romashova, E. B. (2022) · Agricultural science Euro-North-East · doi:10.30766/2072-9081.2022.23.5.587-599 · Cited by 2
Bertuletti, S., Ferrandi, E. E., Monti, D., Fronza, G., Bassanini, I., & Riva, S. (2021) · ChemCatChem · doi:10.1002/cctc.202101307 · Cited by 2
Xu, Z., Pei, Y., Wang, H., & Li, X. (2025) · Comparative Biochemistry and Physiology Part D Genomics and Proteomics · doi:10.1016/j.cbd.2025.101530 · Cited by 1
(2026) · doi:10.3389/fphar.2026.1769883 · Cited by 1
Li, Z., Wang, S., Wang, D., Wang, Y., Mai, M., Ruan, Y., Mo, B., Li, Z., & Guo, H. (2026) · PharmaNutrition · doi:10.1016/j.phanu.2026.100504 · Cited by 2
A practical chemical synthesis of avicholic acid
Chu, H., Yang, K., Li, H., Xie, Y., Yang, H., Zhao, J., Tang, Y., & Xu, L. H. (2024) · Tetrahedron Letters · doi:10.1016/j.tetlet.2024.155045 · Cited by 2
Jhinjharia, D., Singh, S., & Sahi, S. (2024) · International Journal of Pharmaceutical Sciences and Drug Research · doi:10.25004/ijpsdr.2024.160313
Profiling the organ membrane proteome dysregulation in the context of liver diseasePreprint
Antony, F., Brough, Z., Orangi, M., Aoki, H., Babu, M., & Duong, F. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.05.588300 · Cited by 1
Urinary tetrahydroxy bile acids investigation in infantile cholestasis
Albassam, M. M. (2022) · Medical Science · doi:10.54905/disssi/v26i125/ms293e2283
Kotb, M. A., Satar, E. A. E., Badr, A. M., Abdalla, N. A., & Abdelaziz, I. A. (2023) · Gene Expression · doi:10.14218/ge.2022.00008 · Cited by 1
Mullapudi, T. R., Ravi, P. R., & Thipparapu, G. (2023) · Journal of Analytical Science & Technology · doi:10.1186/s40543-023-00408-y
Znaczenie kwasów żółciowych w terapii wybranych chorób
Boguszewska, A., & Kiersztan, A. (2024) · Postępy Biochemii · doi:10.18388/pb.2021_506
Evaluation of Fasting Bile Acid Levels in Pregnant Women Diagnosed with Hyperemesis Gravidarum
Küçükyurt, A. K., Cetin, A., Tanrıkulu, C., & Basat, D. (2024) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog5109206
Liver Steatosis: From Lipotoxicity to Cellular Damage
Puengel, T., & Tacke, F. (2024) · Springer eBooks · doi:10.1007/978-981-97-9519-2_4 · Cited by 3
Keszei, Z., Richter, F. C., Colaço, H. G., Baumgartner, M., Antonio-Herrera, L., Siller, M., Hofmann, A., Viczenczová, C., Baazim, H., Fuchs, C. D., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.17.670599
Diagnostic approach to genetically-determined cholestatic liver diseases in adult patients
Herta, T., & Berg, T. (2025) · Digestive and Liver Disease · doi:10.1016/j.dld.2025.08.088
Gündoğdu, A., Arıkan, M., Ulas, A., Koldaş, S. S., & Ece, G. T. (2025) · Next research. · doi:10.1016/j.nexres.2025.100846 · Cited by 3
Li, X., Xie, K., Jia-Guo, D. E. N. G., Wu-Cheng, C. U. I., LI, G.-M., Hu, Y., & Ji-Hong, D. A. I. (2025) · Acta Hydrobiologica Sinica · doi:10.3724/1000-3207.2025.2025.0189
Bapir, A. A., Salih, B. A., & Othman, G. Q. (2025) · Advances in Redox Research · doi:10.1016/j.arres.2025.100145
Metadata
- Authors
- Evangelakos, I., Heeren, J., Verkade, E., & Kuipers, F.
- Affiliations
- University Medical Center Hamburg-Eppendorf (DE)
- University Medical Center Groningen (NL)
- Venue
- Seminars in Immunopathology
- Published
- 2021-07-08
- Volume
- 43
- Issue
- 4
- Pages
- 577-590
- ISSN
- 1863-2297 (ISSN-L)
- 1863-2300
- PMC
- PMC8443512
- OpenAlex
- W3179865180
- Cited by
- 121
- References
- 107
- Citations by year
- 2026: 23 · 2025: 24 · 2024: 23 · 2023: 23 · 2022: 23 · 2021: 5
- FWCI
- 2.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Seminars in Immunopathology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, cc-by)
- Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion, cc-by)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
- Funders
- Deutsche Forschungsgemeinschaft (SFB841)
- ICIN Netherlands Heart Institute (DCVA grant 2018-27)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- bile acids, bile acid signaling, inflammatory liver disease, cholestatic liver disease, metabolic liver disease, gut microbiota, secondary bile acids, farnesoid X receptor, vitamin D receptor, TGR5, immune regulation, muricholic acids, humanized mice, bile acid receptors
- MeSH terms
- Gastrointestinal Microbiome, Animals, Bile Acids and Salts, Humans, Liver, Liver Diseases, Signal Transduction, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.